Aburi, a seasoned politician, is now a political ally of Trade CS Peter Munya and a fierce critic of Meru
Governor Kiraitu Murungi, despite campaigning for him in 2017.
The arrangement was approved by approximately 99.79% of the votes cast by all of the Merus
shareholders eligible to vote at the meeting.
Kari Tuomala, Managing Director of Merus
Power said, "Data centres, hospitals and airports are demanding applications from availability and reliability point of view.
active harmonic filters have been designed and tested to keep these requirements in mind," says Kari Tuomala, Managing Director of Merus
"This ruling is a reminder of the importance of candor in obtaining and enforcing a patent and as the third and final counterclaim in this suit upon which Merus
has prevailed, it further supports our position that my client--a company dedicated to developing better ways to treat cancer--should never have been burdened with this litigation," Carson told WIPL.
Pursuant to the contract, Dacha will complete the balance of the earlier announced investment of around USD11m in Merus
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Merus
B.V.'s corporate website, SEC filings, investor presentations and featured press releases, both from Merus
Robert S Pollock has acquired ownership of 2,187,500 common shares of Merus
Labs International Inc, and 606,250 common share purchase warrants of Merus
pending deal to acquire all of the issued and outstanding common shares of Canadian specialty pharmaceutical company Merus
Labs International Inc.'s (TSX: MSL) (NASDAQ: MSLI) has been approved by the Spanish anti-trust authority, the Comision Nacional de los Mercados y la Competencia, the company said.
5 June 2017 - Canadian specialty pharmaceutical company Merus
Labs International Inc.
Total revenue for the fourth quarter of 205 of $296.5 million included Merus
revenue of $6.0 million.
(MRUS) announced a settlement of all pending patent litigation and administrative proceedings between Merus
and Regeneron Pharmaceuticals (REGN) pertaining to certain antibody generation platforms of each company.